181 related articles for article (PubMed ID: 11928616)
1. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].
Gotić M; Cvetković M; Bozanović T; Cemerikić V
Srp Arh Celok Lek; 2001; 129(11-12):304-8. PubMed ID: 11928616
[TBL] [Abstract][Full Text] [Related]
2. Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.
Bohîlţea RE; Cîrstoiu MM; Ionescu CA; Niculescu-Mizil E; Vlădăreanu AM; Voican I; Dimitriu M; Turcan N
Medicine (Baltimore); 2017 Nov; 96(46):e8735. PubMed ID: 29145319
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a.
Milano V; Gabrielli S; Rizzo N; Vianelli N; Gugliotta L; Orsini LF; Baravelli S; Pilu GL; Bovicelli L
J Matern Fetal Med; 1996; 5(2):74-8. PubMed ID: 8796772
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.
Ianotto JC; Boyer-Perrard F; Gyan E; Laribi K; Cony-Makhoul P; Demory JL; De Renzis B; Dosquet C; Rey J; Roy L; Dupriez B; Knoops L; Legros L; Malou M; Hutin P; Ranta D; Schoenwald M; Andreoli A; Abgrall JF; Kiladjian JJ
Br J Haematol; 2013 Sep; 162(6):783-91. PubMed ID: 23848933
[TBL] [Abstract][Full Text] [Related]
5. Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b.
Seewann HL; Zikulnig R; Gallhofer G; Schmid C
Eur J Cancer; 1991; 27 Suppl 4():S58-62; discussion S62-3. PubMed ID: 1799482
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
Barosi G; Liberato LN; Costa A; Ascari E
Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
[TBL] [Abstract][Full Text] [Related]
7. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
[TBL] [Abstract][Full Text] [Related]
8. Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy.
Gilbert HS
Cancer; 1998 Sep; 83(6):1205-13. PubMed ID: 9740087
[TBL] [Abstract][Full Text] [Related]
9. [IgG lambda-type multiple myeloma associated with myelofibrosis accompanied by thrombocytosis].
Takada M; Umeda M; Shikoshi K; Shirai T
Rinsho Ketsueki; 1991 Sep; 32(9):1001-5. PubMed ID: 1942535
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Alvarado Y; Cortes J; Verstovsek S; Thomas D; Faderl S; Estrov Z; Kantarjian H; Giles FJ
Cancer Chemother Pharmacol; 2003 Jan; 51(1):81-6. PubMed ID: 12497210
[TBL] [Abstract][Full Text] [Related]
11. [Alpha interferon treatment of idiopathic myelofibrosis].
Cervantes F; Alcorta I; Escoda L; Montserrat E; Rozman C
Med Clin (Barc); 1993 Oct; 101(13):498-500. PubMed ID: 8231385
[TBL] [Abstract][Full Text] [Related]
12. [Successful pregnancy and delivery during alpha-interferon therapy for essential thrombocythemia].
Iki S; Usuki K; Kotaki M; Yamaguchi Y; Urabe A
Rinsho Ketsueki; 1999 Nov; 40(11):1201-3. PubMed ID: 10624133
[TBL] [Abstract][Full Text] [Related]
13. [Pregnancy-related thrombocytosis].
Jønsson V; Bock JE; Mortensen TH; Staun M; Thorsen S
Ugeskr Laeger; 2002 Aug; 164(34):3946-9. PubMed ID: 12212474
[TBL] [Abstract][Full Text] [Related]
14. A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis.
Nakamura F; Andoh A; Minamiguchi H; Hodohara K; Fujiyama Y; Bamba T
Acta Haematol; 1997; 97(4):222-4. PubMed ID: 9158665
[TBL] [Abstract][Full Text] [Related]
15. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
Remes K; Pelliniemi TT
Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
[No Abstract] [Full Text] [Related]
16. Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha.
Kikawa Y; Fukumoto Y; Obata K; Tamura S; Takeuchi M; Tanizawa A; Mayumi M
J Pediatr Hematol Oncol; 1998; 20(5):463-6. PubMed ID: 9787320
[TBL] [Abstract][Full Text] [Related]
17. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.
Khoury N; Chang J; Gru AA; Whyte MP
J Clin Endocrinol Metab; 2012 Sep; 97(9):3051-5. PubMed ID: 22730513
[TBL] [Abstract][Full Text] [Related]
18. [Investigation and treatment of prefibrotic/early primary myelofibrosis. A case study].
Magyari F; Bedekovics J; Décsy J; Ilonczai P; Illés Á; Simon Z
Orv Hetil; 2018 Apr; 159(15):603-609. PubMed ID: 29631428
[TBL] [Abstract][Full Text] [Related]
19. Management of myelofibrosis during pregnancy: a case report.
Zivković R; Marković O; Marisavljević D; Terzić T; Tukić L
Vojnosanit Pregl; 2015 Apr; 72(4):383-5. PubMed ID: 26040188
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia.
Barosi G; Liberato LN; Costa A; Buratti A; Di Dio F; Salvatore S; Ascari E
Eur J Haematol Suppl; 1990; 52():12-4. PubMed ID: 2279538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
